Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has received a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026. The certificate confirms that securities received for dematerialisation were confirmed (accepted/rejected) to the depositories and that securities comprised in the said certificates have been listed on the stock exchanges.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has provided additional information regarding their corporate announcements dated October 06, 2026, on acquisitions, submitted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has issued a general update to correct inadvertent typographical errors in financial metrics of target entities disclosed in a previous filing.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has announced the acquisition of an equity stake in Splendid Hospitals Private Limited (Kompally) for up to Rs. 40.00 Cr through primary infusion.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has announced the acquisition of a 51% equity stake in Sarvottam Health Care Private Limited, an O & M entity, for up to Rs. 80.00 Cr. The acquisition is expected to be completed by October 31, 2026.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has announced the acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for ₹15 Crore. The acquisition is expected to be completed by October 31, 2026. The target entity is a state-of-the-art quaternary care facility with a current capacity of 316 beds and potential for expansion to over 500 beds.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has announced the acquisition of up to 51% equity stake in Insignia Healthcare Private Limited, an O & M entity, for a strategic investment. The acquisition is expected to be completed within 12 to 24 months.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has announced the closure of its trading window for the consideration of unaudited financial results for the 2nd quarter and half-year ending 30th September 2026, from 1st October 2026 until 48 hours after the announcement of the results.

Krishna Institute of Medical Sciences Ltd

Catalyst Trusteeship Limited has acquired 2,80,08,979 shares of Krishna Institute of Medical Sciences Ltd through pledge of equity shares by Bhaskara Rao Bollineni and Bollineni Seenaiah Naidu in favour of Catalyst Trusteeship Limited.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd held its 24th AGM on 27.08.2026, with voting results and scrutinizer's report available on the company's website. The meeting was conducted through video conferencing, with 97610 shareholders on record. Resolutions were passed for the audited financial statements, appointment of a director, and ratification of the cost auditor's remuneration.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd held its 24th Annual General Meeting on August 27, 2026, through video conferencing. The meeting was attended by 71 members, and the proceedings were recorded. The Board of Directors presented the financial statements, and the shareholders ratified the remuneration payable to the Cost Auditors. The meeting also approved granting loans, giving guarantees, and providing securities under section 185 of the Companies Act, 2013.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd (KIMS) has issued a clarification regarding an article published in Dealstreetasia.com stating that the company is in talks to acquire a stake in Renova Hospitals for $52 million. KIMS denies the report as false, baseless, and factually incorrect.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has entered into an Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals Private Limited for an initial term of 5 years.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has allotted 77,02,182 warrants on a preferential basis to Dr. Abhinay Bollineni, Mr. Adwik Bollineni, and Bharas Ventures LLP, raising Rs. 1,499,999,944.50. The warrants are convertible into equity shares within 18 months.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has announced its Q1 FY '27 earnings, with total revenue of INR 1,196 crore, a growth of 36.1% year-on-year and 10.3% on quarter-on-quarter basis. EBITDA of INR 240 crore, a growth of 20.1% on year-on-year and 10.9% on quarter-on-quarter basis. PAT at INR 37 crores in Quarter 1, '27 against INR 85 crore and INR 33 crores in Q1 FY '26 and Q4 FY '26 respectively.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has received in-principle approval from BSE and NSE for the issue and allotment of 77,02,182 warrants convertible into equity shares to promoters/promoter group on a preferential basis.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd (KIMS) has published a newspaper notice for its 24th Annual General Meeting (AGM) to be held on August 27, 2026, through video conferencing. The notice is also available on the company's website.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has dispatched a letter to shareholders regarding the Annual Report for the Financial Year 2025-26 and has also announced the 24th Annual General Meeting (AGM) scheduled to be held on 27th August, 2026.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, along with an Independent Practitioners' Reasonable Assurance Report. The report highlights the company's approach to environmental stewardship, social responsibility, and sound governance.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has submitted its 24th Annual Report for the FY 2025-26, highlighting its expansion with excellence and empathy, with a network of 26 branches across 5 states. The report showcases the company's clinical excellence, patient outreach, and financial performance.